tert-Butyl 3-oxoazetidine-1-carboxylate:Exports & Compliance White Paper 2026

I. Executive Summary

tert-Butyl 3-oxoazetidine-1-carboxylate, CAS 398489-26-4, is the Boc-protected form of azetidin-3-one and one of the workhorse four-membered-ring building blocks of medicinal chemistry. Its significance is disproportionate to its tonnage: the strained azetidine ring appears in a growing number of drug substances, and this reagent is the common entry point for installing a 3-substituted azetidine. This paper addresses sourcing managers, process chemists and regulatory officers.

Three characteristics drive purchasing. The molecule is technically unforgiving: ring strain and an electrophilic ketone make it prone to nucleophilic ring opening, while the acid-labile Boc group means degradation if stored warm or damp. It is analytically awkward: the ketone chromophore is weak, so purity control leans on gas chromatography, refractive index or charged aerosol detection and quantitative nuclear magnetic resonance. And it is commercially graded: catalogue non-good manufacturing practice material and documented good manufacturing practice intermediate campaigns serve different customers at different prices.

Supply decisions therefore turn on more than price per kilogram. Buyers should specify the synthetic route family, the impurity panel including de-Boc and ring-opened species, water content, packaging and cold-chain arrangements, and the documentation tier, meaning non-GMP catalogue supply or an ICH Q7-aligned intermediate campaign with registered starting material justification. This document addresses industrial and research procurement only and contains no therapeutic, dosing or consumer guidance.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

The value of the molecule is structural rather than pharmacological. Azetidine is a four-membered saturated nitrogen heterocycle whose ring strain and compact geometry give it distinctive conformational behaviour, and it is increasingly used as a bioisostere for piperidine, pyrrolidine and morpholine in lead optimisation. The Boc group renders the nitrogen inert during downstream chemistry and is removed under acid when the ring is to be functionalised.

• Ring strain and electrophilic reactivity: The substance is C8H13NO3 with a molecular weight of about 171 grams per mole, and its reactivity follows from ring strain roughly twice that of a five-membered ring combined with a C3 carbonyl that withdraws electron density. Nucleophiles therefore attack the carbonyl and can open the strained ring rather than simply adding to it, and water, alcohols, amines and residual acid are the practical enemies of shelf life.
• Thermal and moisture sensitivity: The product is a low-melting crystalline solid, so warm storage or transit without temperature control can soften, cake or partially liquefy a drum, after which the material no longer charges reproducibly. Acidic impurities or acidic contact surfaces cleave the Boc group with loss of isobutene and carbon dioxide, generating free azetidin-3-one, which is unstable and normally handled as a salt. Cold, dry, inert, light-protected storage is standard.

2.2 Synthesis and Manufacturing Technologies

Industrial routes converge on building the azetidin-3-ol ring first, oxidising it to the ketone, then installing the Boc group. The order matters: the free azetidin-3-one is difficult to isolate and store, so protection is the final operation and the product is the first isolable, handleable form in the sequence.

• Azetidine ring construction and oxidation: The classical sequence reacts epichlorohydrin with a primary amine such as benzylamine to give an N-protected 3-hydroxyazetidine, then oxidises the alcohol to the ketone. Oxidation is the main route differentiator: TEMPO with hypochlorite in biphasic aqueous systems is increasingly favoured for cost and waste profile, Swern offers selectivity at the price of cryogenic operation and dimethyl sulfide, and hypervalent iodine reagents avoid both but generate expensive iodine-containing waste.
• Deprotection and Boc installation: The N-benzyl group is removed by catalytic hydrogenolysis over palladium on carbon, and the liberated azetidin-3-one is immediately protected with di-tert-butyl dicarbonate under basic conditions. Critical controls are carbon dioxide evolution and exotherm management on scale, suppression of di-Boc and tert-butoxycarbonate by-products, and removal of palladium to ICH Q3D expectations for good manufacturing practice campaigns.

2.3 Core Application Matrix

• Pharmaceutical intermediate for azetidine-containing drug substances: The dominant use is as the entry point to 3-substituted azetidines. Reduction gives 3-hydroxyazetidine derivatives and reductive amination gives 3-aminoazetidine derivatives, both of which appear as substituents in publicly disclosed drug substances, notably in the azetidine-bearing kinase inhibitor and fluoroquinolone antibacterial families. Buyers in this segment purchase kilogram quantities under defined specifications and expect full traceability of route and impurities.
• Medicinal chemistry and lead optimisation: Contract research organisations and discovery groups buy gram to hundred-gram quantities for scaffold-hopping and structure-activity work, using the azetidine ring to raise three-dimensional character, lower lipophilicity and block metabolic soft spots relative to larger saturated rings. This segment values breadth of catalogue availability, fast delivery, small pack sizes and reliable analytical documentation over the lowest unit price.
• Process development and analytical standard work: A third use supports route scouting, forced-degradation and impurity identification programmes, where the compound and its known related substances, meaning de-Boc material, ring-opened amino alcohols and halohydrin precursors, are needed as markers. Laboratories in this segment require characterised reference material with assigned content and documented uncertainty rather than bulk supply.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Demand tracks pipeline composition rather than macroeconomic cycles. As more azetidine-containing candidates enter development and as approved products containing the ring reach commercial scale, orders move from gram-scale discovery purchases to multi-kilogram campaigns with validated specifications. A second shift is the growing expectation that a building block supplier can also run a documented GMP intermediate campaign, which converts a catalogue transaction into a qualified supply relationship with change control.

3.2 Capacity Distribution and Export Flows

Capacity is fragmented by tier rather than concentrated. Chinese producers in the eastern coastal provinces supply most bulk building-block volume, supported by integrated epichlorohydrin and protected-amine chemistry. Indian suppliers around Hyderabad and Bengaluru serve catalogue and contract research demand with strong English-language documentation. European and North American fine-chemical houses occupy the high-specification tier, holding REACH registrations and supplying small documented lots at premium prices.

3.3 Market Bifurcation and Pricing Dynamics

Pricing is strongly tiered. Catalogue non-good manufacturing practice material trades on unit price and availability, with compression as multiple producers qualify for the same specification. Documented good manufacturing practice intermediate supply carries a premium reflecting analytical work, change control and audit readiness rather than chemistry cost. Price is sensitive to epichlorohydrin and di-tert-butyl dicarbonate cost, palladium price and whether oxidation requires cryogenic or chromatographic operations.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

As a chemical intermediate this compound does not enjoy the reliefs available to active substances used in authorised medicinal products, so its chemical-law obligations are full. When sold into a regulated campaign it inherits ICH Q7 expectations and may be designated a registered starting material under ICH Q11. Suppliers therefore run two documentation regimes in one facility.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

• REACH registration and intermediate status: Placement above one tonne per year requires registration, and the medicinal-product relief does not apply because this is a synthetic intermediate rather than an active substance in an authorised medicine. Registration as a transported isolated intermediate under strictly controlled conditions can reduce data requirements but imposes documented containment and customer confirmation obligations. Below the threshold, product and process oriented research and development notification may cover genuine development supply.
• CLP classification and downstream communication: Safety data sheets for this class commonly carry GHS07 irritant labelling with skin irritation, serious eye irritation and specific-target-organ single-exposure statements, and classification and labelling inventory notification follows placement rather than tonnage. Downstream pharmaceutical users also require an extended data sheet covering ICH Q3C residual solvents, ICH Q3D elemental impurities and absence of animal-derived inputs.

4.2 North American Market: TSCA, EPA, and FDA Regulations

• TSCA inventory status and import certification: Before shipment into the United States, suppliers must confirm whether the substance is on the TSCA inventory. Non-listed substances require a premanufacture notice or an exemption, with the research-and-development exemption available only for material used exclusively for research under technically qualified supervision and not for commercial sale. Every import requires a section 13 certification, positive or negative.
• Quality expectations in a regulated campaign: Where the intermediate is bought for an ICH Q7 campaign, buyers expect a defined specification, a validated or verified method, impurity identification above reporting thresholds, residual solvent and elemental impurity data, and change-control notification. If the material is designated a registered starting material under ICH Q11, the justification must address where impurity control begins and why downstream purification clears them.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

Sustainability pressure on building blocks is transmitted through pharmaceutical customers rather than imposed directly, and it focuses on solvent intensity, oxidation chemistry and waste from protection-group chemistry.

5.1 Carbon Footprint and Circular Economy

The oxidation step dominates the environmental profile. Swern chemistry requires cryogenic cooling and generates dimethyl sulfide with its abatement burden, whereas TEMPO-catalysed hypochlorite oxidation runs near ambient temperature with a far better mass and energy profile, while hypervalent iodine reagents trade those problems for expensive iodine-containing waste. Producers also recover solvents by distillation, replace chromatography with crystallisation, and run the exothermic aminolysis in continuous flow.

5.2 Sustainable Sourcing and Traceability

Traceability expectations cover three inputs. Epichlorohydrin is increasingly available from glycerin-derived bio-based routes, and customers with Scope 3 targets ask which route applies. Di-tert-butyl dicarbonate chemistry is atom-inefficient, releasing tert-butanol and carbon dioxide, so recovery matters to mass metrics. Palladium should come from a refiner with recognised chain-of-custody certification and should be recovered. Buyers also expect ISO 9001, ISO 14001 and REACH declarations.

VI. Supply Chain Resilience and Export Logistics

Logistics for this compound are governed by its low melting point and its moisture sensitivity, not by hazard class. A shipment that arrives warm or damp is a quality failure even if the paperwork is perfect, so temperature and moisture control are the design constraints.

6.1 Packaging Standards and Moisture/Contamination Control

• Cold-chain packaging for a low-melting solid: Material is packed in amber glass or high-density polyethylene bottles inside insulated shippers with gel packs or phase-change material validated for the lane, with a calibrated temperature logger and a defined excursion procedure. Customers should confirm that packaging is validated against a worst-case lane profile rather than assuming ambient shipping is adequate in warm seasons.
• Moisture barrier and inert atmosphere: The inner container is sealed under nitrogen or argon with desiccant and a humidity indicator, then bagged in a moisture-barrier laminate with a second desiccant before drumming. Acidic or unlined metal contact is avoided because trace acid catalyses Boc cleavage. On receipt, buyers should test water content by Karl Fischer titration and confirm identity and purity before release.

6.2 Dangerous Goods Identification and Transit Protocols

The substance is not normally a dangerous good under ADR, IMDG or IATA, so consignments move as ordinary chemicals with GHS irritant labelling, although classification should be checked lot by lot. Air freight is common for high-value small lots and sea freight for bulk campaigns, with cold-chain packaging for the former and refrigerated containers for the latter in hot seasons. Classification falls within Chapter 29 heterocyclic headings, most commonly 2933.

VII. Enterprise Global Expansion Strategy Guide

Suppliers that grow in this segment move up the value ladder rather than competing on unit price. Three moves define that path.

1. Offer two documented tiers and make the boundary explicit: Maintain a non-GMP catalogue grade with a clear specification, realistic retest period and cold-chain packaging, and a separate GMP intermediate campaign offering with ICH Q7-aligned documentation, change control, impurity identification and audit access. Publishing the boundary prevents the common failure mode in which a discovery-grade customer assumes regulatory support that was never contracted, or a GMP customer discovers mid-campaign that the route was never validated.
2. Invest in analytical credibility: Because ultraviolet detection understates impurities here, a supplier able to show gas chromatography with flame ionisation detection, refractive index or charged aerosol detection and quantitative nuclear magnetic resonance content assignment, with characterised de-Boc and ring-opened standards, removes the largest source of dispute on receipt. Adding residual solvent, elemental impurity and water data to the certificate is inexpensive and differentiating.
3. Secure chemical-law position before seeking volume: European registration or defensible intermediate status, TSCA inventory confirmation and import certification capability, and complete CLP documentation are prerequisites for selling into regulated geographies at scale. Sequencing this before commercial expansion avoids winning a campaign and then discovering the placing-on-the-market position was never established.

VIII. Conclusion

tert-Butyl 3-oxoazetidine-1-carboxylate is a small molecule that rewards operational discipline. Ring strain makes it reactive, the Boc group makes it acid-sensitive, the low melting point makes it a cold-chain product, and the weak chromophore makes it analytically demanding, so the differentiators between suppliers are specification depth, packaging and documentation rather than nominal purity claims.

Demand will follow azetidine-containing pipelines, and the commercial centre of gravity will keep shifting from catalogue transactions toward documented intermediate campaigns with change control. Buyers should qualify on route, impurity panel, water content and analytical method rather than price alone, and should verify on receipt. This document addresses industrial and research procurement only.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global tert-Butyl 3-oxoazetidine-1-carboxylate Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global tert-Butyl 3-oxoazetidine-1-carboxylate supply chain:

• China — integrated building-block and custom-synthesis base: Producers in the eastern coastal provinces combine epichlorohydrin and protected-amine chemistry with custom-synthesis capacity able to run kilogram campaigns quickly. The strengths are cost, scale and responsiveness; the improvement areas are cold-chain discipline for low-melting material and documentation depth for European compliance.
• India — catalogue and contract research supply: The Hyderabad and Bengaluru cluster serves discovery and contract research demand with broad catalogues, small pack sizes and strong English-language technical documentation. Its capability in documented good manufacturing practice intermediate campaigns is growing, supported by ICH Q7 audit experience for export customers.
• European Union and North America — high-specification registrants: Fine-chemical houses in these regions hold REACH registrations, supply small fully documented lots at premium prices and maintain the analytical infrastructure to characterise difficult impurities. They are favoured where tonnage is modest, documentation demands are high and supply-chain proximity is valued over unit price.